Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes(Tilt Biotherapeutics)

N/A

Report date: 2023/12/14 20:00:50

Base Information

Drug NameAdoptive Cell Therapy With Tumor Infiltrating Lymphocytes(Tilt Biotherapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmarkFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTilt Biotherapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTilt Biotherapeutics Ltd

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A